2017 Annual Meeting

Session: Multivariate Modeling and Quality-by-Control Approaches for Pharmaceutical Processes

This session is focused on the advances in the application of multivariate statistical approaches (both latent variable and other approaches) to support the development and manufacture of medicine through the reduction of variability or deviation; i.e. increasing process robustness. These approaches can include data visualization, statistical process control algorithms, chemometrics, and chemical or biochemical process modeling for drug product and drug substance applications. Contributions for both industry and academia are encouraged.

Chair

Albrecht, J., Bristol-Myers Squibb

Co-Chair

Seibert, K., Eli Lilly and Company